EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation

Lorena Herrador iD, José González-Costello, Jordi Niubo-Bosch, Laura Calatayud-Samper, Alba Maestro-Benedicto, Marta Farrero-Torres, Teresa Blasco-Peiro iD, Luis Almenar-Bonet, Zorba Blázquez-Bermejo, Iris Garrido-Bravo, Ferran Gran-Ipiña iD, Antonio Grande-Trillo iD und 2 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199434 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lorena Herrador und 13 weiteren Autor:innen. Beteiligte Einrichtung: Heart Failure and Heart Transplant Unit, Cardiology Department, Bio-Heart Cardiovascular Diseases Research Group, Hospital Universitari de Bellvitge,…. Hauptthemen laut MEDLINE: Brain Death, Primary Graft Dysfunction, Tissue Donors, Heart Transplantation. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hospital Universitari de Bellvitge and Bellvitge Biomedical Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary graft dysfunction (PGD) remains a major cause of early morbidity and mortality after a heart transplant (HTx). Understanding the donor-related mechanisms involved may help improve organ selection and post-HTx outcomes. This study aimed to explore the association between the donor serum biomarkers of cell death and inflammation and the incidence of PGD and rejection in HTx recipients. We conducted a retrospective, multicenter observational study of brain-dead (DBD) heart donors and corresponding recipients between 2013 and 2019. Donor blood samples were analyzed for inflammatory cytokines, cell death-related proteins, and mitochondrial (mtDNA) and genomic DNA (gDNA). A total of 39 donor–recipient pairs were included. Sixteen recipients developed severe PGD, and five experienced ≥2R cellular rejection. Donors whose recipients developed PGD had significantly lower serum Caspase-3 levels compared to those without PGD (391.6 [101.8–1003.3] vs. 65.3 [40.2–163.3] pg/mL; p = 0.04). A trend toward lower mtDNA/gDNA ratio was also observed in the same group (10.5 [5.4–24.6] vs. 6.5 [3.3–10.7]; p = 0.067). Lower Caspase-3 levels in donor serum were significantly associated with the development of severe PGD in recipients. This may suggest that the sublethal activation of apoptotic pathways in the donor could play a protective role, potentially conditioning the graft to tolerate ischemic injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain DeathPrimary Graft DysfunctionTissue DonorsHeart TransplantationCaspase 3HumansMaleFemaleMiddle AgedAdultRetrospective StudiesBiomarkersDNA, MitochondrialGraft Rejection

Stichwörter der Autor:innen

Caspase-3allograft rejectionbrain death donorcell death processinflammatory mediatorsmitochondrial DNAprimary graft disfunction

Substanzen

Caspase 3BiomarkersCASP3 protein, humanDNA, Mitochondrial

Autor:innen und Institutionen

  • Heart Failure and Heart Transplant Unit, Cardiology Department, Bio-Heart Cardiovascular Diseases Research Group, Hospital Universitari de Bellvitge, Universitat de Barcelona, L'Hospitalet de Llobregat, 08907 Barcelona,…
  • Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.
  • Microbiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, 08907 Barcelona, Spain.
  • Heart Failure and Heart Transplant Unit, Cardiology Department, Hospital de la Santa Creu i Sant Pau, 08025 Barcelona, Spain.
  • Heart Failure and Heart Transplant Unit, Cardiology Department, Hospital Clínic Barcelona, 08036 Barcelona, Spain.

ORCID-Profile: Lorena Herrador, Teresa Blasco-Peiro, Ferran Gran-Ipiña, Antonio Grande-Trillo, Gabriel Moreno-Gonzalez

Förderung

  • Hospital Universitari de Bellvitge and Bellvitge Biomedical Research Institute

Zitieren

APA

Herrador, L., González-Costello, J., Niubo-Bosch, J., Calatayud-Samper, L., Maestro-Benedicto, A., Farrero-Torres, M., Blasco-Peiro, T., Almenar-Bonet, L., Blázquez-Bermejo, Z., Garrido-Bravo, I., Gran-Ipiña, F., Grande-Trillo, A., Manito, N., & Moreno-Gonzalez, G. (2025). Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199434

Vancouver

Herrador L, González-Costello J, Niubo-Bosch J, Calatayud-Samper L, Maestro-Benedicto A, Farrero-Torres M, et al. Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199434

BibTeX
@article{Herrador2025,
  author = {Herrador, Lorena and González-Costello, José and Niubo-Bosch, Jordi and Calatayud-Samper, Laura and Maestro-Benedicto, Alba and Farrero-Torres, Marta and Blasco-Peiro, Teresa and Almenar-Bonet, Luis and Blázquez-Bermejo, Zorba and Garrido-Bravo, Iris and Gran-Ipiña, Ferran and Grande-Trillo, Antonio and Manito, Nicolas and Moreno-Gonzalez, Gabriel},
  title = {Caspase-3 in Brain Death Donors Is Associated with Reduced Primary Graft Dysfunction After Heart Transplantation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199434}
}
Kostenlos starten →